Stay updated on PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Sign up to get notified when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-11-03T16:56:10.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision number also changes from v3.7.1 to v3.7.2.
    Difference
    0.3%
    Check dated 2026-10-20T17:11:27.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-06T18:54:58.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page's revision label changed from Revision: v3.6.6 to Revision: v3.7.0, indicating a software update to the ClinicalTrials.gov interface.
    Difference
    0.0%
    Check dated 2026-09-15T22:20:00.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.5 to v3.6.6. This indicates a minor software update to the site interface.
    Difference
    0.0%
    Check dated 2026-09-01T19:34:52.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Revision: v3.6.5 replaces the previous v3.6.4, updating the page's displayed site revision. This signals a new build/version of the ClinicalTrials.gov interface without altering the underlying study records.
    Difference
    0.0%
    Check dated 2026-08-11T14:57:20.000Z thumbnail image

Stay in the know with updates to PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.